Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 30;11(3):275-288.
doi: 10.1007/s41649-019-00094-2. eCollection 2019 Sep.

Precision Medicine and Big Data: The Application of an Ethics Framework for Big Data in Health and Research

Affiliations

Precision Medicine and Big Data: The Application of an Ethics Framework for Big Data in Health and Research

G Owen Schaefer et al. Asian Bioeth Rev. .

Abstract

As opposed to a 'one size fits all' approach, precision medicine uses relevant biological (including genetic), medical, behavioural and environmental information about a person to further personalize their healthcare. This could mean better prediction of someone's disease risk and more effective diagnosis and treatment if they have a condition. Big data allows for far more precision and tailoring than was ever before possible by linking together diverse datasets to reveal hitherto-unknown correlations and causal pathways. But it also raises ethical issues relating to the balancing of interests, viability of anonymization, familial and group implications, as well as genetic discrimination. This article analyses these issues in light of the values of public benefit, justice, harm minimization, transparency, engagement and reflexivity and applies the deliberative balancing approach found in the Ethical Framework for Big Data in Health and Research (Xafis et al. 2019) to a case study on clinical genomic data sharing. Please refer to that article for an explanation of how this framework is to be used, including a full explanation of the key values involved and the balancing approach used in the case study at the end. Our discussion is meant to be of use to those involved in the practice as well as governance and oversight of precision medicine to address ethical concerns that arise in a coherent and systematic manner.

Keywords: Big data; Bioethics; Genetic discrimination; Genomics; Precision medicine.

PubMed Disclaimer

References

    1. Ballantyne, Angela, and Cameron Stewart. 2019. Big Data and Public-Private Partnerships in Healthcare and Research: The Application of an Ethics Framework for Big Data in Health and Research. Asian Bioethics Review 11 (3). 10.1007/s41649-019-00100-7. - PMC - PubMed
    1. Bayer R, Galea S. Public health in the precision-medicine era. New England Journal of Medicine. 2015;373(6):499–501. doi: 10.1056/NEJMp1506241. - DOI - PubMed
    1. Blasimme, Alessandro, Effy Vayena, and Ine Van Hoyweghen. 2019. Big data, precision medicine and private insurance: a delicate balancing act. Big Data & Society 6 (1): 205395171983011. 10.1177/2053951719830111.
    1. Chaudhary R, Garg J, Shah N, Sumner A. PCSK9 inhibitors: a new era of lipid lowering therapy. World Journal of Cardiology. 2017;9(2):76. doi: 10.4330/wjc.v9.i2.76.. - DOI - PMC - PubMed
    1. Ciardiello F, Arnold D, Casali PG, Cervantes A, Douillard J-Y, Eggermont A, Eniu A, et al. Delivering precision medicine in oncology today and in future—the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO) Annals of Oncology. 2014;25(9):1673–1678. doi: 10.1093/annonc/mdu217. - DOI - PubMed

LinkOut - more resources